Mackay Shields LLC Biogen Inc. Transaction History

Mackay Shields LLC

$581 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$187.54 - $223.02 $3.99 Million - $4.75 Million	-21,286 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $160,829 - $202,636	-830 Reduced 3.75%	21,286 $4.48 Million
Q4 2021 Feb 04, 2022	SELL	$223.92 - $287.77 $184,062 - $236,546	-822 Reduced 3.58%	22,116 $5.31 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $308,176 - $401,895	-1,089 Reduced 4.53%	22,938 $6.49 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $8.41 Million - $13.5 Million	-32,490 Reduced 57.49%	24,027 $8.32 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $9.62 Million - $11.3 Million	-39,587 Reduced 41.19%	56,517 $15.8 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $1.4 Million - $2.11 Million	5,933 Added 6.58%	96,104 $23.5 Million
Q3 2020 Nov 04, 2020	SELL	$264.77 - $305.71 $185,603 - $214,302	-701 Reduced 0.77%	90,171 $25.6 Million
Q2 2020 Jul 31, 2020	BUY	$258.66 - $342.55 $1.84 Million - $2.44 Million	7,109 Added 8.49%	90,872 $24.3 Million
Q1 2020 May 08, 2020	SELL	$268.85 - $341.04 $5.57 Million - $7.06 Million	-20,715 Reduced 19.83%	83,763 $26.5 Million
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $5.98 Million - $8.27 Million	27,193 Added 35.19%	104,478 $31 Million
Q3 2019 Nov 01, 2019	SELL	$217.44 - $243.88 $5.94 Million - $6.66 Million	-27,300 Reduced 26.1%	77,285 $18 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $310,514 - $342,275	1,416 Added 1.37%	104,585 $24.5 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $1.8 Million - $2.82 Million	8,317 Added 8.77%	103,169 $24.4 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $985,333 - $1.25 Million	-3,538 Reduced 3.6%	94,852 $28.5 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $13.5 Million - $17.7 Million	46,136 Added 88.29%	98,390 $34.8 Million
Q2 2018 Aug 06, 2018	SELL	$257.52 - $306.91 $3.72 Million - $4.43 Million	-14,448 Reduced 21.66%	52,254 $15.2 Million
Q1 2018 May 03, 2018	BUY	$260.13 - $367.91 $17.4 Million - $24.5 Million	66,702 New	66,702 $18.3 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Account